| Literature DB >> 25152855 |
Fabio Cianchi1, Giuseppe Macrì2, Giampiero Indennitate3, Beatrice Mallardi4, Giacomo Trallori2, Maria Rosa Biagini2, Benedetta Badii5, Fabio Staderini5, Giuliano Perigli5.
Abstract
Laparoscopic total gastrectomy (LTG) is not a commonly performed procedure due to the difficulty associated with surgical reconstruction. We present our preliminary results after intracorporeal circular stapling esophagojejunostomy using the newly developed transorally inserted anvil (OrVil™, Covidien, MA, USA). Between 2008 and June 2013, 51 patients underwent laparoscopic gastrectomy with D2 lymph node dissection for gastric cancer. A total of 12 patients underwent LTG: of these, 5 received an intracorporeal linear side-to-side esophagojejunal anastomosis and the remaining 7 underwent intracorporeal circular stapling esophagojejunostomy using the OrVil™ system. Short-term outcomes were compared between the two groups. There were no intraoperative complications or conversions to open surgery in any patients. The mean operative time was significantly shorter in the OrVil™ than in the side-to-side group (261.4 ± 12.0 vs 333.0 ± 15.0 minutes, respectively, p = 0.005). Postoperative fluorography revealed no anastomosis leakage or stenosis in either groups. All patients resumed an oral liquid diet on postoperative day 5 and the mean postoperative hospital stay was 9 days. Intracorporeal circular stapling esophagojejunostomy using the OrVil™ system is technically feasible and safe in LTG. This technique may be considered a simple and time-saving alternative to the side-to-side linear esophagojejunostomy.Entities:
Keywords: Esophagojejunal anastomosis; Gastric cancer; Intracorporeal circular stapling; Laparoscopic total gastrectomy
Year: 2014 PMID: 25152855 PMCID: PMC4141073 DOI: 10.1186/2193-1801-3-434
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Comparison of demographic characteristics and surgical outcomes between the side-to-side esophagojejunal anastomosis and the OrVil™ group
| Side-to-side esophagojejunal anastomosis N. 5 | Esophagojejunal anastomosis with OrVil™ N. 7 |
| |
|---|---|---|---|
|
| 66 ± 6.8 | 74.1 ± 3.0 | NS |
|
| 3:2 | 6:1 | NS |
|
| 26.5 ± 0.9 | 25.5 ± 1.1 | NS |
|
| 0 | 0 | NS |
|
| 2 (40%) | 4 (57.1%) | NS |
| Hypertension | 1 | 2 | |
| Diabetes mellitus | 1 | 0 | |
| Heart diseases | 0 | 1 | |
| Chronic lung diseases | 0 | 1 | |
|
| 333.0 ± 15.0 | 261.4 ± 12.0 | 0.005 |
|
| 126.7 ± 12.7 | 115 ± 9.6 | NS |
|
| 0 | 0 | NS |
|
| 29 ± 2.4 | 32.4 ± 4.2 | NS |
Figure 1Intracorporeal anvil insertion using the OrVil™ system. A. As the OrVil™ tube reaches the esophageal stump, a small hole is created on the stump. B. The tube is pulled out through the hole, until the anvil reaches the esophageal stump. C. The tube is disconnected from the anvil by cutting the connecting thread and then removed from the abdominal cavity. D. Laparoscopic view after completion of the transoral anvil insertion.
Figure 2Intracorporeal circular stapling technique. A. A circular stapler is introduced into the abdomen through the left midclavicular line port which is extended to a length of 4–6 cm. B. After pneumoperitoneum is re-established, the circular stapler is inserted into the jejunum. C. Double-stapling esophagojejeunostomy is performed under direct laparoscopic view. D. Laparoscopic view after completion of the anastomosis.